Home/Filings/4/0001209191-23-031817
4//SEC Filing

PFORZHEIMER CARL H II 4

Accession 0001209191-23-031817

CIK 0000006176other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 9:35 AM ET

Size

18.1 KB

Accession

0001209191-23-031817

Insider Transaction Report

Form 4
Period: 2020-09-22
Transactions
  • Exercise of In-Money

    Common Stock

    2020-09-22$3.50/sh+714$2,4992,314 total(indirect: See Footnote)
  • Exercise/Conversion

    Common Stock

    2022-07-22$4.00/sh+714$2,8563,028 total(indirect: See Footnote)
  • Exercise of In-Money

    Series A Warrant (right to buy)

    2020-09-22+1,6001,600 total(indirect: See Footnote)
    Exercise: $2.57From: 2020-09-22Exp: 2025-08-01Common Stock (714 underlying)
  • Exercise of In-Money

    Subscription Rights (right to buy)

    2020-09-221,6000 total(indirect: See Footnote)
    Exercise: $1.56From: 2020-08-18Exp: 2020-09-18Units consisting of Common Stock and Series A Warrants
  • Exercise/Conversion

    Series A Warrant (right to buy)

    2022-07-221,6000 total(indirect: See Footnote)
    Exercise: $2.57From: 2020-09-22Exp: 2025-08-01Common Stock (714 underlying)
Holdings
  • Common Stock

    141,383
Footnotes (6)
  • [F1]This Form 4 is being filed to include the acquisition of shares of common stock and Series A Warrants that had been inadvertently omitted.
  • [F2]Represents the conversion of a subscription right issued by the Issuer as part of a rights offering that closed on September 22, 2020 (the "Rights Offering"). Each subscription right was exercisable for units that consisted of (i) 0.4464 shares of common stock and (ii) a Series A warrant exercisable to acquire 0.4464 shares of common stock at an exercise price of $2.5668 (or $5.75 per whole share of common stock under the Series A warrants). The subscription price of each unit was $1.5624 per unit (or $3.50 per whole share of common stock and Series A warrants to purchase a whole share of common stock). The securities issued upon conversion of the subscription rights are exempted from Section 16(b) pursuant to Rule 16b-3.
  • [F3]Shares are held equally between two different trusts, including half of the shares that are held by a trust of which Reporting Person is a trustee and principal beneficiary and the other half are held by a trust of which Reporting Person is a trustee in which he disclaims beneficial ownership.
  • [F4]Represents the conversion of Series A warrants issued by the Issuer as part of the Rights Offering, converted at the temporarily discounted price of $1.7856 per Series A warrant (or $4.00 per whole share of the Issuer's common stock). Beginning May 31, 2022 and expiring at 11:59 p.m. Eastern Time on July 15, 2022, the Issuer through an offer to exercise offered holders of the Issuer's outstanding Series A warrants the opportunity to exercise their Series A warrants at the temporarily reduced exercise price of $1.7856 per Series A warrant (or $4.00 per whole share of the Corporation's common stock).
  • [F5]Other than between May 31, 2022 and before 11:59 p.m. Eastern Time on July 15, 2022, when each Series A warrant represented the right to purchase 0.4464 shares of common stock at a temporarily reduced exercise price of $1.7856 per each Series A warrant, each Series A warrant represents the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668 per series A warrant (or $5.75 per whole share of the Issuer's common stock). The Series A warrants are exercisable only for whole numbers of shares of Common Stock.
  • [F6]Series A warrants were issued on September 22, 2020 upon the conversion of a subscription right issued by the Issuer as part of a rights offering. Each subscription right was exercisable for units that consisted of (i) 0.4464 shares of common stock and (ii) a Series A warrant exercisable to acquire 0.4464 shares of common stock at an exercise price of $2.5668 (or $5.75 per whole share of common stock under the Series A warrants). The subscription price of each unit was $1.5624 per unit (or $3.50 per whole share of common stock and Series A warrants to purchase a whole share of common stock). The securities issued upon conversion of the subscription rights are exempted from Section 16(b) pursuant to Rule 16b-3.

Issuer

AMPCO PITTSBURGH CORP

CIK 0000006176

Entity typeother

Related Parties

1
  • filerCIK 0001190987

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 9:35 AM ET
Size
18.1 KB